166 related articles for article (PubMed ID: 30345502)
1. Whole synthetic pathway engineering of recombinant protein production.
Brown AJ; Gibson SJ; Hatton D; Arnall CL; James DC
Biotechnol Bioeng; 2019 Feb; 116(2):375-387. PubMed ID: 30345502
[TBL] [Abstract][Full Text] [Related]
2. Synthetic promoters for CHO cell engineering.
Brown AJ; Sweeney B; Mainwaring DO; James DC
Biotechnol Bioeng; 2014 Aug; 111(8):1638-47. PubMed ID: 24615264
[TBL] [Abstract][Full Text] [Related]
3. Model-directed engineering of "difficult-to-express" monoclonal antibody production by Chinese hamster ovary cells.
Pybus LP; Dean G; West NR; Smith A; Daramola O; Field R; Wilkinson SJ; James DC
Biotechnol Bioeng; 2014 Feb; 111(2):372-85. PubMed ID: 24081924
[TBL] [Abstract][Full Text] [Related]
4. Integrated cell and process engineering for improved transient production of a "difficult-to-express" fusion protein by CHO cells.
Johari YB; Estes SD; Alves CS; Sinacore MS; James DC
Biotechnol Bioeng; 2015 Dec; 112(12):2527-42. PubMed ID: 26126657
[TBL] [Abstract][Full Text] [Related]
5. Multiplex secretome engineering enhances recombinant protein production and purity.
Kol S; Ley D; Wulff T; Decker M; Arnsdorf J; Schoffelen S; Hansen AH; Jensen TL; Gutierrez JM; Chiang AWT; Masson HO; Palsson BO; Voldborg BG; Pedersen LE; Kildegaard HF; Lee GM; Lewis NE
Nat Commun; 2020 Apr; 11(1):1908. PubMed ID: 32313013
[TBL] [Abstract][Full Text] [Related]
6. Model-Driven Engineering of N-Linked Glycosylation in Chinese Hamster Ovary Cells.
Stach CS; McCann MG; O'Brien CM; Le TS; Somia N; Chen X; Lee K; Fu HY; Daoutidis P; Zhao L; Hu WS; Smanski M
ACS Synth Biol; 2019 Nov; 8(11):2524-2535. PubMed ID: 31596566
[TBL] [Abstract][Full Text] [Related]
7. An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer.
McLeod J; O'Callaghan PM; Pybus LP; Wilkinson SJ; Root T; Racher AJ; James DC
Biotechnol Bioeng; 2011 Sep; 108(9):2193-204. PubMed ID: 21445882
[TBL] [Abstract][Full Text] [Related]
8. Precision control of recombinant gene transcription for CHO cell synthetic biology.
Brown AJ; James DC
Biotechnol Adv; 2016; 34(5):492-503. PubMed ID: 26721629
[TBL] [Abstract][Full Text] [Related]
9. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
[TBL] [Abstract][Full Text] [Related]
10. Engineering Biology to Construct Microbial Chassis for the Production of Difficult-to-Express Proteins.
Kim K; Choe D; Lee DH; Cho BK
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024292
[TBL] [Abstract][Full Text] [Related]
11. CHO genome mining for synthetic promoter design.
Johari YB; Brown AJ; Alves CS; Zhou Y; Wright CM; Estes SD; Kshirsagar R; James DC
J Biotechnol; 2019 Mar; 294():1-13. PubMed ID: 30703471
[TBL] [Abstract][Full Text] [Related]
12. Disposable bioreactors for inoculum production and protein expression.
Eibl R; Löffelholz C; Eibl D
Methods Mol Biol; 2014; 1104():265-84. PubMed ID: 24297422
[TBL] [Abstract][Full Text] [Related]
13. An 'omics approach towards CHO cell engineering.
Datta P; Linhardt RJ; Sharfstein ST
Biotechnol Bioeng; 2013 May; 110(5):1255-71. PubMed ID: 23322664
[TBL] [Abstract][Full Text] [Related]
14. Engineering the cellular protein secretory pathway for enhancement of recombinant tissue plasminogen activator expression in Chinese hamster ovary cells: effects of CERT and XBP1s genes.
Rahimpour A; Vaziri B; Moazzami R; Nematollahi L; Barkhordari F; Kokabee L; Adeli A; Mahboudi F
J Microbiol Biotechnol; 2013 Aug; 23(8):1116-22. PubMed ID: 23676904
[TBL] [Abstract][Full Text] [Related]
15. A hybrid approach identifies metabolic signatures of high-producers for chinese hamster ovary clone selection and process optimization.
Popp O; Müller D; Didzus K; Paul W; Lipsmeier F; Kirchner F; Niklas J; Mauch K; Beaucamp N
Biotechnol Bioeng; 2016 Sep; 113(9):2005-19. PubMed ID: 26913695
[TBL] [Abstract][Full Text] [Related]
16. Quantitative intracellular flux modeling and applications in biotherapeutic development and production using CHO cell cultures.
Huang Z; Lee DY; Yoon S
Biotechnol Bioeng; 2017 Dec; 114(12):2717-2728. PubMed ID: 28710856
[TBL] [Abstract][Full Text] [Related]
17. Engineering CHO cells to overexpress a secreted reporter protein upon induction from mouse mammary tumor virus promoter.
James RI; Elton JP; Todd P; Kompala DS
Biotechnol Bioeng; 2000 Jan; 67(2):134-40. PubMed ID: 10592510
[TBL] [Abstract][Full Text] [Related]
18. Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system.
Zhou H; Liu ZG; Sun ZW; Huang Y; Yu WY
J Biotechnol; 2010 May; 147(2):122-9. PubMed ID: 20371256
[TBL] [Abstract][Full Text] [Related]
19. Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system.
Orlova NA; Kovnir SV; Gabibov AG; Vorobiev II
BMC Biotechnol; 2017 Mar; 17(1):33. PubMed ID: 28340620
[TBL] [Abstract][Full Text] [Related]
20. NF-κB, CRE and YY1 elements are key functional regulators of CMV promoter-driven transient gene expression in CHO cells.
Brown AJ; Sweeney B; Mainwaring DO; James DC
Biotechnol J; 2015 Jul; 10(7):1019-28. PubMed ID: 25612069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
